Myositis (Idiopathic Inflammatory Myopathies) Summary

Networked: 2206 relevant articles (87 outcomes, 222 trials/studies) for this Disease

Key Drugs and Agents for Myositis

1. Intravenous Immunoglobulins (IVIG) : 10 outcomes 13 studies in 41 results : FDA 1
   
2. rituximab (Mabthera) : 10 outcomes 12 studies in 41 results : FDA 3
   
3. Immunoglobulins (Immunoglobulin) : 9 outcomes 7 studies in 53 results : IBA
   
4. Cyclosporine (Ciclosporin) : 9 outcomes 1 study in 27 results : FDA 20 Generic
   
5. Autoantibodies : 7 outcomes 26 studies in 320 results : IBA
   
6. Prednisolone (Predate) : 6 outcomes 1 study in 19 results : FDA 55 Generic
   
7. Antibodies : 5 outcomes 15 studies in 294 results : IBA
   
8. Prednisone (Sone) : 5 outcomes 3 studies in 19 results : FDA 119 Generic
   
9. Adrenal Cortex Hormones (Corticosteroids) : 5 outcomes 1 study in 61 results : IBA
   
10. Tacrolimus (Prograf) : 4 outcomes 3 studies in 14 results : FDA 7 Generic
    

Diseases Related to Myositis

1. Interstitial Lung Diseases (Interstitial Lung Disease)
2. Dermatomyositis (Dermatopolymyositis)
3. Polymyositis
4. Infection
5. Myositis (Idiopathic Inflammatory Myopathies)

Key Therapies for Myositis

1. Immunotherapy : 2 outcomes 1 study in 11 results
   
2. Immunomodulation : 2 outcomes 1 study in 7 results
   
3. Drug Therapy (Chemotherapy) : 1 outcome in 18 results
   
4. Plasmapheresis : 1 outcome in 10 results
   
5. Therapeutics : 1 outcome in 2 results